KEROS THERAPEUTICS, INC. (KROS) Stock buybacks 2024–2025
KEROS THERAPEUTICS, INC. (KROS) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$375.0MFY2025 · since FY2024: $0 → $375.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $375.0M | — |
| FY2024 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice